Amended and restated term sheet no. 14-A
To prospectus dated December 1, 2005,
prospectus supplement dated October 12, 2006 and
product supplement no. 34-V dated February 7, 2007

  Term Sheet No. 14-A to
Product Supplement No. 34-V
Registration Statement No. 333-130051
Dated April 9, 2007; Rule 433

     

Structured 
Investments 

     

JPMorgan Chase & Co.
$
Reverse Exchangeable Notes due April 28, 2008
Linked to the Common Stock of a Single Reference Stock Issuer

General

Key Terms

Payment at Maturity:

The payment at maturity, in excess of any accrued and unpaid interest, is based on the performance of the Reference Stock. You will receive $1,000 for each $1,000 principal amount note, plus any interest accrued and unpaid to the final Interest Payment Date, unless:

 

(1)

the Final Share Price is less than the Initial Share Price; and
(2) on any day during the Monitoring Period, the closing price of the Reference Stock has declined, as compared to the Initial Share Price, by more than the Protection Amount.
  If the conditions described in both (1) and (2) are satisfied, at maturity you will receive, in addition to any accrued and unpaid interest, instead of the principal amount of your notes, the number of shares of the Reference Stock equal to the Physical Delivery Amount (or, at our election, the Cash Value thereof). Fractional shares will be paid in cash. The market value of the Physical Delivery Amount or the Cash Value thereof will most likely be substantially less than the principal amount of your notes, and may be zero.
Maturity Date: April 28, 2008*
Pricing Date: On or about April 24, 2007
Settlement Date: On or about April 27, 2007
Observation Date: April 23, 2008*
Interest Payment Date: Interest on the notes will be payable monthly in arrears on the 27th calendar day of each month, except for the final interest payment, which shall be payable on the Maturity Date (each such date, an “Interest Payment Date”), commencing on May 27, 2007, to and including the Interest Payment Date corresponding to the Maturity Date. See “Selected Purchase Considerations — Monthly Interest Payments” in this term sheet no. 14-A for more information.
Monitoring Period: The period from the Pricing Date to and including the Observation Date.
Physical Delivery Amount: The number of shares of the Reference Stock, per $1,000 principal amount note, equal to $1,000 divided by the Initial Share Price, subject to adjustments.
Cash Value: For the Reference Stock, the amount in cash equal to the product of (1) $1,000 divided by the Initial Share Price of such Reference Stock and (2) the Final Share Price of such Reference Stock, subject to adjustments.
Initial Share Price: The closing price of the Reference Stock on the Pricing Date. The Initial Share Price is subject to adjustments in certain circumstances. See “Description of Notes – Payment at Maturity” and “General Terms of the Notes — Anti-dilution Adjustments” in the accompanying product supplement no. 34-V for further information about these adjustments.
Final Share Price: The closing price of the Reference Stock on the Observation Date.

 

 

 

 

 

 

 

 

 

Approximate Tax Allocation of
Monthly Coupon per $1,000
Principal Amount Note
††

Reference
Stock

Page
Number

Ticker
Symbol

Principal
Amount

Coupon
Rate

Protection
Amount

Initial
Share Price

CUSIP

Approximate
Monthly
Coupon

Interest on
Deposit

Put
Premium

Cisco
Systems, Inc.

TS-3

CSCO

 

9.30%

20% of the
Initial Share Price

 

48123JVU0

$7.75

$4.32

$3.43

*

   Subject to postponement in the event of a market disruption event and as described under “Description of Notes — Payment at Maturity” in the accompanying product supplement no. 34-V.
  This term sheet no. 14-A amends and restates and supersedes term sheet no. 14 and term sheet no. 14-S to product supplement no. 34-V (term sheet no. 14 is available on the SEC Web site at http://www.sec.gov/Archives/edgar/data/19617/000089109207001343/e26870_fwp.pdf) (and term sheet no. 14-S is available on the SEC Web site at http://www.sec.gov/Archives/edgar/data/19617/000089109207001371/e26892_fwp.pdf) solely with respect to notes linked to the common stock of Cisco Systems, Inc., but does not amend or restate or supersede term sheet no. 14 or term sheet no. 14-S with respect to notes linked to any other Reference Stock. You should rely only on the information contained in this term sheet no. 14-A and in the documents indicated under “Additional Terms Specific to the Notes” in making your decision to invest in notes linked to the common stock of Cisco Systems, Inc.
††   Based on one reasonable treatment of the notes, as described herein under “Selected Purchase Considerations — Tax Treatment as a Unit Comprising a Put Option and a Deposit” and in the accompanying product supplement no. 34-V under “Certain U.S. Federal Income Tax Consequences” on page PS-24. The allocations presented herein were determined as of April 6, 2007; the actual allocations will be determined as of the pricing date and may differ.

Investing in the Reverse Exchangeable Notes involves a number of risks. See “Risk Factors” beginning on page PS-6 of the accompanying product supplement no. 34-V and “Selected Risk Considerations” beginning on page TS-2 of this term sheet no. 14-A.

JPMorgan Chase & Co. has filed a registration statement (including a prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this term sheet no. 14-A relates. Before you invest, you should read the prospectus in that registration statement, each prospectus supplement, product supplement no. 34-V and any other documents relating to this offering that JPMorgan Chase & Co. has filed with the SEC for more complete information about JPMorgan Chase & Co. and this offering. You may get these documents without cost by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, JPMorgan Chase & Co., any agent or any dealer participating in this offering will arrange to send you the prospectus, each prospectus supplement, product supplement no. 34-V and this term sheet no. 14-A if you so request by calling toll-free 866-535-9248.

You may revoke your offer to purchase the notes at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of, or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.

Neither the SEC nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this term sheet no. 14-A or the accompanying prospectus supplements and prospectus. Any representation to the contrary is a criminal offense.


 

Price to Public

Fees and Commissions (1)

Proceeds to Us


Per note

$

$

$


Total

$

$

$


(1)

In no event will the fees and commissions received by J.P. Morgan Securities Inc., whom we refer to as JPMSI, which includes concessions to be allowed to other dealers, exceed $60.00 per $1,000 principal amount note for the offering listed above. For more detailed information about fees and commissions and concessions, please see “Supplemental Underwriting Information” on the last page of this term sheet no. 14-A.

The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.

JPMorgan

April 9, 2007



ADDITIONAL TERMS SPECIFIC TO THE NOTES

You should read this term sheet no. 14-A together with the prospectus dated December 1, 2005, as supplemented by the prospectus supplement dated October 12, 2006 relating to our Series E medium-term notes of which these notes are a part, and the more detailed information contained in product supplement no. 34-V dated February 7, 2007. This term sheet no. 14-A, together with the documents listed below, contains the terms of the notes and, except as set forth in the next sentence, supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours. This term sheet no. 14-A amends and restates and supersedes term sheet no. 14 dated April 3, 2007 and term sheet no. 14-S dated April 4, 2007 to product supplement no. 34-V solely with respect to notes linked to the common stock of Cisco Systems, Inc., but does not amend or restate or supersede term sheet no. 14 or term sheet no. 14-S with respect to notes linked to any other Reference Stock. You should rely only on the information contained in this term sheet no. 14-A and in the documents listed below in making your decision to invest in notes linked to the common stock of Cisco Systems, Inc. You may rely on the information contained in term sheet no. 14 dated April 3, 2007 or term sheet no. 14-S dated April 4, 2007 and in the documents listed below in making your decision to invest in notes linked to any other Reference Stock. You should carefully consider, among other things, the matters set forth in “Risk Factors” in the accompanying product supplement no. 34-V, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the notes.

You may access these documents on the SEC Web site at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC Web site):

Our Central Index Key, or CIK, on the SEC Web site is 19617. As used in this term sheet no. 14-A, the “Company,” “we,” “us,” or “our” refers to JPMorgan Chase & Co.

Selected Purchase Considerations


JPMorgan Structured Investments —
Reverse Exchangeable Notes Linked to the Common Stock of a Single Reference Stock Issuer
 TS-1

Selected Risk Considerations

An investment in the notes involves significant risks. Investing in the notes is not equivalent to investing directly in the Reference Stock. These risks are explained in more detail in the “Risk Factors” section of the accompanying product supplement no. 34-V dated February 7, 2007.


JPMorgan Structured Investments —
Reverse Exchangeable Notes Linked to the Common Stock of a Single Reference Stock Issuer
 TS-2


The Reference Stock

Public Information

All information contained herein on the Reference Stock and on the Reference Stock issuer is derived from publicly available sources and is provided for informational purposes only. Companies with securities registered under the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act, are required to periodically file certain financial and other information specified by the SEC. Information provided to or filed with the SEC by the Reference Stock issuer pursuant to the Exchange Act can be located by reference to the SEC file number provided below and can be accessed through www.sec.gov. We do not make any representation that these publicly available documents are accurate or complete. See “The Reference Stock” beginning on page PS-13 of the accompanying product supplement no. 34-V for more information.

Cisco Systems, Inc. (“Cisco Systems”)

According to its publicly available filings with the SEC, Cisco Systems designs, manufactures and sells networking and other products related to the communications and information technology industry and provides services associated with these products and their use . The common stock of Cisco Systems, par value $.001 per share, is listed on the NASDAQ Stock Market, which we refer to as the Relevant Exchange for purposes of Cisco Systems in the accompanying product supplement no. 34-V. Cisco Systems’ SEC file number is 000-18225.

Historical Information of the Common Stock of Cisco Systems

The following graph sets forth the historical performance of the common stock of Cisco Systems based on the weekly closing price (in U.S. dollars) of the common stock of Cisco Systems from January 4, 2002 through April 5, 2007. The closing price of the common stock of Cisco Systems on April 5, 2007 was $26.06. We obtained the closing prices and other information below from Bloomberg Financial Markets, without independent verification. The closing prices and this other information may be adjusted by Bloomberg Financial Markets for corporate actions such as public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy. We make no representation or warranty as to the accuracy or completeness of the information obtained from Bloomberg Financial Markets.

Since its inception, the price of the common stock of Cisco Systems has experienced significant fluctuations. The historical performance of the common stock of Cisco Systems should not be taken as an indication of future performance, and no assurance can be given as to the closing prices of the common stock of Cisco Systems during the term of the notes. We cannot give you assurance that the performance of the common stock of Cisco Systems will result in the return of any of your initial investment. We make no representation as to the amount of dividends, if any, that Cisco Systems will pay in the future. In any event, as an investor in the notes, you will not be entitled to receive dividends, if any, that may be payable on the common stock of Cisco Systems.



JPMorgan Structured Investments —
Reverse Exchangeable Notes Linked to the Common Stock of a Single Reference Stock Issuer
 TS-3

Examples of Hypothetical Payment at Maturity for a $1,000 Investment in the Notes Linked to the Common Stock of Cisco Systems

The following table illustrates hypothetical payments at maturity on a $1,000 investment in the notes linked to the common stock of Cisco Systems, based on a range of hypothetical Final Share Prices of the Reference Stock and assuming that the closing price of the Reference Stock declines in the manner set forth in the column titled “Hypothetical lowest closing price during the Monitoring Period.” For this table of hypothetical payments at maturity, we have also assumed the following:

    • the Initial Share Price: $26.00 • the Protection Amount: $5.20
  • the Coupon Rate: 9.30%  


Hypothetical lowest
closing price during the
Monitoring Period

Hypothetical
Final Share
Price

Payment at Maturity

Total Value of
Payment Received
at Maturity*


$26.00

$50.00

$1,000.00

$1,000.00


$13.00

$27.00

$1,000.00

$1,000.00


$26.00

$26.00

$1,000.00

$1,000.00


$20.80

$20.80

$1,000.00

$1,000.00


$13.00

$25.00

38 shares of the Reference Stock or the
Cash Value thereof

$961.54


$13.00

$13.00

38 shares of the Reference Stock or the
Cash Value thereof

$500.00


$5.00

$5.00

38 shares of the Reference Stock or the
Cash Value thereof

$192.31


$0.00

$0.00

38 shares of the Reference Stock or the
Cash Value thereof

$0.00


* Note that you will receive at maturity any accrued and unpaid interest in cash, in addition to either shares of the Reference Stock (or, at our election, the Cash Value thereof) or the principal amount of your note in cash. Also note that if you receive the Physical Delivery Amount, the total value of payment received at maturity shown in the table above includes the value of any fractional shares, which will be paid in cash.

The following examples illustrate how the total value of payments received at maturity set forth in the table above are calculated.

Example 1: The lowest closing price of the Reference Stock during the Monitoring Period was $13.00 but the Final Share Price is $27.00. Because the Final Share Price of $27.00 is greater than the Initial Share Price of $26.00, you will receive a payment at maturity of $1,000 per $1,000 principal amount note.

Example 2: The lowest closing price of the Reference Stock during the Monitoring Period was $13.00 and the Final Share Price is $25.00. Because the Final Share Price of $25.00 is less than the Initial Share Price of $26.00 and the closing price of the Reference Stock declined by more than the Protection Amount on at least one day during the Monitoring Period, you will receive the Physical Delivery Amount of shares of the Reference Stock, or at our election, the Cash Value thereof, at maturity. Because the Final Share Price of the Reference Stock is $25.00, the total value of your final payment at maturity, whether in cash or shares of the Reference Stock, is $961.54.

Example 3: The closing price of the Reference Stock between the Pricing Date and before the Observation Date does not reflect a decline of more than the Protection Amount. However, the closing price of the Reference Stock on the Observation Date is $13.00, a decline of more than the Protection Amount. Because the Final Share Price of $13.00 is less than the Initial Share Price of $26.00 and the Final Share Price has declined by more than the Protection Amount, you will receive the Physical Delivery Amount, or at our election, the Cash Value thereof, at maturity. Because the Final Share Price of the Reference Stock is $13.00, the total value of your final payment at maturity, whether in cash or shares of the Reference Stock, is $500.

Example 4: The Final Share Price of $20.80 is less than the Initial Share Price of $26.00 but does not decline by more than the Protection Amount and the closing price of the Reference Stock does not decline by more than the Protection Amount on any day during the Monitoring Period. Because the closing price of the Reference Stock has not declined by more than the Protection Amount, you will receive a payment at maturity of $1,000 per $1,000 principal amount note, even though the Final Share Price of $20.80 is less than the Initial Share Price of $26.00.

Regardless of the performance of the Reference Stock or the payment you receive at maturity, you will receive interest payments, for each $1,000 principal amount note, in the aggregate amount of approximately $93.00 over the term of the notes. If we had priced the notes on April 5, 2007, you would have received 38 shares of the Reference Stock or, at our election, the Cash Value thereof, at maturity, provided the Final Share Price declined from the Initial Share Price and the closing price of the Reference Stock declined by more than the Protection Amount from the Initial Share Price on at least one day during the Monitoring Period. The actual number of shares of the Reference Stock, or the Cash Value thereof, you receive at maturity and the actual Protection Amount applicable to your notes may be more or less than the amounts displayed in this hypothetical and will depend in part on the closing price of the Reference Stock on the pricing date.


JPMorgan Structured Investments —
Reverse Exchangeable Notes Linked to the Common Stock of a Single Reference Stock Issuer
 TS-4

Supplemental Underwriting Information

If the notes linked to the common stock of Cisco Systems priced today, JPMSI, acting as agent for JPMorgan Chase & Co., would receive a commission of approximately $25.00 per $1,000 principal amount note and would use a portion of that commission to allow selling concessions to other dealers of approximately $22.50 per $1,000 principal amount note. The concessions of $22.50 include concessions to be allowed to selling dealers and concessions to be allowed to an arranging dealer. The actual commission received by JPMSI may be more or less than $25.00 and will depend on market conditions on the pricing date. In no event will the commission received by JPMSI, exceed $60.00 per $1,000 principal amount note.

See “Underwriting” beginning on page PS-29 of the accompanying product supplement no. 34-V.


JPMorgan Structured Investments —
Reverse Exchangeable Notes Linked to the Common Stock of a Single Reference Stock Issuer
 TS-5